硫代硫酸钠对难治性尿毒症皮肤瘙痒症患者的疗效及其对生存质量的影响

摘要
图/表
参考文献(24)
相关文章 (15)

全文: PDF (468 KB) HTML (1 KB)
输出: BibTeX | EndNote (RIS)

摘要目的探讨硫代硫酸钠在难治性尿毒症皮肤瘙痒症患者中的疗效及其对生存质量的影响。方法选取2020年1 月至2022 年12 月北京市海淀医院和济宁市第一人民医院收治的102 例维持性规律血液透析治疗伴有皮肤瘙痒症患者作为研究对象，按随机数字表法分为对照组（51 例）和观察组（51 例）。对照组针对瘙痒患者保持皮肤湿润，局部冷敷，结合口服抗组胺药物等处理；观察组在每次透析下机前静脉推注硫代硫酸钠。比较两组患者的血肌酐（SCr），尿素氮（BUN），血液透析尿素清除指数（Kt/V），血钙（Ca）：血磷（P），甲状旁腺激素（PTH）及皮肤瘙痒视觉模拟评分（VAS），并评价两组疗效，评估两组的生活质量，观察是否出现毒副反应和患者的耐受情况。结果观察组患者在接受硫代硫酸钠治疗8 周后，其SCr、BUN、P、PTH 均低于对照组，Kt/V、Ca 均高于对照组，差异有统计学意义（P＜0.05）。治疗8 周后，观察组的VAS 低于对照组，差异有统计学意义（P＜0.05）。观察组的总有效率高于对照组，差异有统计学意义（P＜0.05）。观察组的生理机能、生理职能、躯体疼痛、总体健康、活力、情感职能、精神健康、社会功能得分均高于对照组，差异有统计学意义（P＜0.05）。两组患者治疗期间均未出现相关毒副反应，患者耐受度良好。结论硫代硫酸钠可有效缓解难治性尿毒症皮肤瘙痒症状，改善患者血肌酐、尿素氮、Kt/V、血钙磷、甲状旁腺激素等指标，对生活质量有显著的积极影响。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章

关键词 ：硫代硫酸钠, 尿毒症皮肤瘙痒症, 皮肤瘙痒评分, 生存质量

Abstract：

Objective To investigate the effect of Sodium Thiosulfate on quality of life and clinical efficacy in hemodialysis patients with refractory uremic pruritus.Methods A total of 102 patients with skin pruritus who were treated with maintenance regular hemodialysis in Beijing Haidian Hospital and Jining No.1 People's Hospital from January 2020 to December 2022 were selected as the research objects.According to the random number table method,they were divided into control group(51 cases)and observation group(51 cases).Patients in the control group were treated with skin moisturization,local cold compress,and oral antihistamine drugs.The observation group received intravenous injection of Sodium Thiosulfate before the completion of dialysis.The serum creatinine (SCr),blood urea nitrogen (BUN),kidney/renal urea clearance multiplied by time divided by volume of distribution of urea(Kt/V),serum calcium(Ca),serum phosphorus(P),parathyroid hormone (PTH)and visual analogue scale (VAS)of skin pruritus were compared between the two groups,and the curative effect was evaluated,the quality of life of the two groups was evaluated,and the side effects and tolerance of the patients were observed.Results After 8 weeks of Sodium Thiosulfate treatment,the SCr,BUN,P and PTH of the observation group were lower than those of the control group,and Kt/V and Ca were higher than those of the control group,and the differences were statistically significant (P＜0.05).After 8 weeks of treatment,the VAS of the observation group was lower than that of the control group,and the difference was statistically significant (P＜0.05).The total effective rate of the observation group was higher than that of the control group,and the difference was statistically significant(P＜0.05).The scores of physical function,role physical,bodily pain,general health,vatality,role emotional,mental health and social function of the observation group were higher than those of the control group,and the differences were statistically significant (P＜0.05).There were no related adverse reactions during treatment in the two groups,and the patients were well tolerated.Conclusion Sodium Thiosulfate can effectively relieve the pruritus of refractory uremia,improve the serum creatinine,urea nitrogen,Kt/V,serum calcium and phosphorus,parathyroid hormone and other indicators of patients,and has a significant positive impact on the quality of life.

Key words： Sodium Thiosulfate Uremic pruritus Skin pruritus score Quality of life

通讯作者: 杨涛（1976-），男，河南鹿邑人，博士，主任医师；研究方向：血液透析、血液透析通路。

作者简介: 刘音（1978-），女，山东寿光人，副主任医师；研究方向：血液透析、血液透析通路。

引用本文:

刘音；赵彬；刘丽芳；胡普平；郭宗运；杨涛. 硫代硫酸钠对难治性尿毒症皮肤瘙痒症患者的疗效及其对生存质量的影响[J]. 中国当代医药, 2024, 31(16): 54-59.
LIU Yin1 ZHAO Bin2 LIU Lifang2 HU Puping2 GUO Zongyun3 YANG Tao1. Effect of Sodium Thiosulfate on quality of life and clinical efficacy in hemodialysis patients with refractory uremic pruritus. 中国当代医药, 2024, 31(16): 54-59.

链接本文:

https://www.dangdaiyiyao.com/CN/ 或 https://www.dangdaiyiyao.com/CN/Y2024/V31/I16/54

[1]	Rayner HC，Larkina M，Wang M，et al.International Comparisons of Prevalence，Awareness，and Treatment of Pruritus in People on Hemodialysis[J].Clin J Am Soc Nephrol，2017，12（12）：2000-2007.
[2]	Scberer JS，Combs SA，Brennan F.Sleep Disorders，Restless legs Syndrome，and Uremic Pruritus：Diagnosis and Treatmentof Common Symptoms in Dialysis Patients[J].Am J Kidney Dis，2017，69（1）：117-128.
[3]	Shah K，Murtagh EM，McGeechan K，et al.Health-related quality of life and well-being in people over 75 years of age with end-stage kidney disease managed with dialysis or comprehensive conservative care：a cross-sectional study in the UK and Australia[J].BMJ Open，2019，9（5）：25-35.
[4]	Shevchenko A，Valdes-Rodriguez R，Yosipovitch G.Causes，pathophysiology，and treatment of pruritus in the mature patient[J].Clin Dermatol，2018，36（2）：140-151.
[5]	Weiss M，Mettang T，Tschulena U，et al.Prevalence of chronic itch and associated factors in haemodialysis patients：a representative cross-sectional study[J].Acta Derm Venereol，2015，95（7）：816-821.
[6]	张慧玲，李烈辉.尿毒症瘙痒症的综合治疗[J].中国医药指南，2018，16（15）：298-299.
[7]	汤曦，石运莹，王俭勤，等.中国成人慢性肾脏病及其并发症早期筛查临床路径专家建议（2023 版）[J].中国实用内科杂志，2023，43（3）：198-205.
[8]	Mettang T，Kremer AE.Uremic pruritus[J].Kidney Int，2015，87（4）：685-691.
[9]	张虹.高通量血液透析联合低钙透析液与普通透析对尿毒症病人皮肤瘙痒评分及血生化指标的影响对比[J].临床医药文献电子杂志，2018，5（5）：90，94.
[10]	吴艳，李永超，钟杰.不同血液净化方式对尿毒症患者瘙痒症状改善及中、大分子毒素清除的影响[J].实用医院临床杂志，2018，15（6）：211-213.
[11]	侯金泓，徐应军，刘俊江.SF36-Ⅱ在血液透析患者中信度、效度、敏感度的评价[J].现代预防医学，2007，34（14）：2646-2648.
[12]	韦泽丰，郑金花，王自强.长时血液透析联合加巴喷丁治疗尿毒症顽固性皮肤瘙痒的效果[J].中国医药科学，2023，13（9）：5-8，98.
[13]	Mettang T，Pauli C，Alscher DM.Uraemic pruritus-new perspectives and insights from recent trials[J].Nephrol Dial Transplant，2002，17（9）：1558-1563.
[14]	徐川岚，明瑶，赵莎，等.从《黄帝内经》理论探讨尿毒症皮肤瘙痒的中医治疗[J].国医论坛，2019，34（3）：11-12.
[15]	刘敏，李金芳，李德娟.中药熏洗结合穴位贴敷在腹膜透析尿毒症皮肤瘙痒患者临床护理中的应用[J].中国当代医药，2023，30（15）：168-171.
[16]	邹露婷，陈胡英，黄稳萍.中药解毒止痒液对尿毒症血液透析患者皮肤瘙痒的疗效观察及护理[J].中国当代医药，2022，29（11）：150-152，156.
[17]	刘钊，廖艳，唐俊.维持性血液透析患者皮肤瘙痒相关发病机制及治疗研究进展[J].中国医学创新，2022，19（15）：170-174.
[18]	Combs SA，Teixeira JP，Germain MJ.Pruritus in kidney disease[J].Semin Nephrol，2015，35（4）：383-391.
[19]	郭焕开，杨晓冉，梁锦云，等.甲状旁腺切除对尿毒症继发性甲状旁腺功能亢进症患者认知功能及生存质量的影响[J].中国当代医药，2018，25（11）：8-10，15.
[20]	Strippoli R，Moreno-Vicente R，Battistelli C，et al.Molecular Mechanisms Underlying Peritoneal EMT and Fibrosis [J].Stem Celis Int，2016：3543678.
[21]	Nigwekar SU，Thadhani R，Brandenburg VM.Calciphylaxis[J].N Engl J Med，2018，378（18）：1704-1714.
[22]	Zhai CJ，Yang XW，Sun J，et al.Efficacy and safety of lanthanum carbonate versus alcium-based phosphate binders in patients with chronic kidney disease：a systematic review and meta-analysis[J].Int Urol Nephrol，2015，47（3）：527-535.
[23]	Nigwekar SU，Brunelli SM，Meade D，et al.Sodium Thiosulfate Therapy for Calcific Uremic Arteriolopathy[J].Clin J Am Soc Nephrol，2013，8（7）：1162-1170.
[24]	Tannor K，Norman BR，Adusei KK，et al.Quality of life among patients with moderate to advanced chronic kidney disease in Ghana-a single centre study[J].BMC Nephrology，2019，20（1）：122.